Entrada Therapeutics

Filed a patent for "intracellular targeting of oligonucleotides" on Thu, August 17, 2023

Filed a patent for "cyclic peptides for delivering therapeutics" on Thu, August 17, 2023

Filed a patent for "intracellular targeting of oligonucleotides" on Thu, August 17, 2023

Filed a patent for "cyclic cell penetrating peptides" on Fri, August 18, 2023

Filed a patent for "compounds for delivering therapeutics" on Fri, February 23, 2024

Filed a patent for "intracellular targeting of oligonucleotides" on Tue, March 5, 2024

Filed a patent for "cyclic peptides for delivering therapeutics" on Tue, March 5, 2024

Filed a patent for "intracellular targeting of oligonucleotides" on Tue, March 5, 2024

Filed a patent for "intracellular targeting of oligonucleotides" on Tue, April 30, 2024

Filed a patent for "cyclic peptides for delivering therapeutics" on Tue, April 30, 2024

Filed a patent for "compounds and methods for skipping exon 44 in duchenne muscular dystrophy" on Thu, February 29, 2024

Filed a patent for "ocular delivery of endosomal escape vehicles" on Wed, November 16, 2022

Filed a patent for "ß-catenin antibodies" on Fri, November 18, 2022

Filed a patent for "cyclic cell penetrating peptides" on Thu, October 5, 2023

Filed a patent for "compositions and methods for delivery of nucleic acid therapeutics" on Wed, April 26, 2023

Filed a patent for "hybrid oligonucleotides" on Thu, April 27, 2023

Filed a patent for "methods for the sequencing of phosphorodiamidate morpholino oligomers (pmo) and peptide-pmo (ppmo) conjugates" on Thu, March 14, 2024

Filed a patent for "compositions and methods for intracellular therapeutics" on Thu, November 9, 2023

Filed a patent for "cyclic cell penetrating peptides" on Thu, July 25, 2024

Filed a patent for "compositions and methods for skipping exon 45 in duchenne muscular dystrophy" on Thu, February 29, 2024

Filed a patent for "ocular delivery of endosomal escape vehicles" on Fri, September 30, 2022

Filed a patent for "cyclic cell penetrating peptides" on Thu, March 31, 2022

Filed a patent for "compounds and methods for skipping exon 44 in duchenne muscular dystrophy" on Thu, March 31, 2022

Filed a patent for "antisense compounds and methods for targeting cug repeats" on Thu, March 31, 2022

Filed a patent for "compounds and methods for skipping exon 44 in duchenne muscular dystrophy" on Mon, April 4, 2022